Back

Empagliflozin: unlocking new potentials in heart failure decongestion

31 August 2024 (14:00 - 14:50)
Organised by: Logo
Congress Presentation Part of: Phenotypic approach in heart failure therapy Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Fahad Khan

Peshawar Institute of Cardiology, Peshawar (Pakistan)

7 More presentations in this session

Presentation thumbnail
In-hospital initiation of Vericiguat and short-term cardiovascular function improvement in heart failure patients with worsened renal function
Professor J. She (Xi'an, CN)
Abstract Slides Video
Presentation thumbnail
Effects of Dapagliflozin on myocardial performance in non-diabetic patients with Heart failure with reduced and mid-range ejection fraction (DAPA ECHO trial)
Doctor M. Pastore (Siena, IT) Doctor A. Stefanini (Siena, IT)
Abstract Slides Video
Presentation thumbnail
Comparison of ventricular tachyarrhythmias in HF patients on dapagliflozin versus empagliflozin
Doctor P. Wilson (Dallas, US)
Abstract Slides Video
Presentation thumbnail
Intermittent levosimendan infusions for advanced heart failure: a systematic review and meta-analysis of randomized controlled trials.
Doctor M. Abouzid (Poznan, PL)
Abstract Slides Video
Presentation thumbnail
Real-world eligibility for GLP1-ra therapy in a cohort of heart failure patients
Doctor A. Villaschi (Milan, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Phenotypic approach in heart failure therapy

The Event

Event poster

ESC Congress 2024

31 August 2024 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Acute effect of empagliflozin on echocardiographic parameter in de novo heart failure: a secondary analysis of the EMPAG-HF trial
thumbnail
Congress Presentation
Effects of early empagliflozin in acute decompensated HFrEF on ventricular systolic and diastolic parameters: interaction with endothelial function and arterial stiffness
thumbnail
Congress Presentation
Gliflozins improve short-term decongestion

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources